(VIANEWS) - Liberty All (USA), PetMed Express (PETS), AbbVie (ABBV) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Liberty All (USA) | 6.97 | -1.27% | 12.2% | 2022-06-05 22:41:14 |
| 2 | PetMed Express (PETS) | 20.77 | 1.66% | 5.87% | 2022-05-25 03:12:05 |
| 3 | AbbVie (ABBV) | 149.01 | -0.09% | 3.67% | 2022-06-08 14:55:27 |
| 4 | AMERISAFE (AMSF) | 51.16 | 1.11% | 2.59% | 2022-06-06 14:23:13 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Liberty All (USA) - Dividend Yield: 12.2%
ALPS Advisers, Inc. launched the Liberty All Star Equity Fund, a closed-ended equity mutual funds. Aristotle Capital Management, LLC, Pzena Investment Management, LLC, Delaware Investments Fund Advisers, Sustainable Growth Advisers, LP, TCW Investment Management Company are co-managers of the fund. The fund invests in American public equity markets. It invests in stocks from companies that operate across diverse sectors. The fund invests mainly in large-cap growth and value stocks. It benchmarks its portfolio performance against the Lipper Large Cap Core Mutual Fund Average and Dow Jones Industrial Average. The NASDAQ Composite Index and the S&P 500 Index are also used to measure the fund's performance. Liberty All Star Equity Fund was established on October 31, 1986. It is based in the United States.
Volume
Today's last reported volume for Liberty All is 779183, 37.37% below its average volume of 1244100.
Liberty All's last close was $6.97, 26.32% below its 52-week high of $9.46.
Liberty All's Revenue
Year-on-year quarterly revenue growth grew by 14.9%, now sitting on 20.7M for the twelve trailing months.
Liberty All's Stock Yearly Top and Bottom Value
Liberty All's stock is valued at $6.97 at 03:15 EST, way below its 52-week high of $9.46 and way higher than its 52-week low of $6.27.
Liberty All's Moving Average
Liberty All's worth is below its 50-day moving average of $7.28 and way under its 200-day moving average of $7.97.More news about Liberty All.
2. PetMed Express (PETS) - Dividend Yield: 5.87%
PetMed Express, Inc., and its affiliates, do business under the name 1-800-PetMeds, operate as an American pet pharmacy. It sells prescription and non-prescription medications for pets, as well as other products that are beneficial to horses, dogs, cats and their health. The company sells non-prescription medication and supplies such as flea, tick, joint and bone care products, vitamins and nutritional supplements, hygiene and products. It also offers prescription medications including heartworm and tick prevention, allergy, asthma, treatment for dermatitis and pain medications. It also offers pet food, beds and crates as well as strollers, stairs, and other supplies. The company sells products via its website, mobile app, telephone contact center, direct mail/print through brochures, catalogs and postcards. PetMed Express, Inc., was established in Delray Beach, Florida in 1996.
Volume
Today's last reported volume for PetMed Express is 453060, 11.21% above its average volume of 407406.
PetMed Express's last close was $20.77, 55.5% under its 52-week high of $46.67.
The company's growth estimates for the present quarter is 18.2% and a drop 3.2% for the next.PetMed Express's Revenue
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 273.42M for the twelve trailing months.
PetMed Express's Stock Yearly Top and Bottom Value
PetMed Express's stock is valued at $20.77 at 03:15 EST, way under its 52-week high of $46.67 and above its 52-week low of $19.09.
PetMed Express's Moving Average
PetMed Express's value is way below its 50-day moving average of $24.09 and way under its 200-day moving average of $26.30.More news about PetMed Express.
3. AbbVie (ABBV) - Dividend Yield: 3.67%
AbbVie Inc. develops and manufactures pharmaceuticals and exports them internationally. HUMIRA is an injectable therapy for BehASSet's and autoimmune diseases. SKYRIZI treats mild to moderate plaque psoriasis in adults. RINVOQ can be used for adults suffering from chronic lymphocytic lung disease (CLL), SLL, or small-cell lymphoma. IMBRUVICA, which treats adults with CLL, SLL, and interferon-free treatment for adults with HCV genotype 4. TECHNIVIE will treat HCV patients. SYNAGIS protects infants with severe respiratory diseases; KALETRA is a prescription medicine for anti-HIV-1; CREON is a treatment for chronic pancreatic disease. AndroGel can be used to treat hypothyroidism. Lupron will also be available for patients suffering from endometriosis, uterine fibroids, advanced prostate cancer and endometriosis. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. The company has collaborated with Calico Life Sciences LLC, Alector, Inc., Janssen Biotech, Inc., Jacobio Pharmaceuticals, Genmab A/S, and Jacobio Pharmaceuticals. It was founded in North Chicago, Illinois in 2012.
Volume
Today's last reported volume for AbbVie is 3348480, 53.79% below its average volume of 7246190.
AbbVie's last close was $149.25, 15.16% below its 52-week high of $175.91.
The company's growth estimates for the current quarter and the next is 10.3% and 10.2%, respectively.AbbVie's Revenue
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 56.73B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,AbbVie's stock is considered to be oversold (<=20).
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $149.01 at 03:16 EST, way under its 52-week high of $175.91 and way above its 52-week low of $105.56.
AbbVie's Moving Average
AbbVie's worth is below its 50-day moving average of $156.27 and way higher than its 200-day moving average of $133.79.More news about AbbVie.
4. AMERISAFE (AMSF) - Dividend Yield: 2.59%
AMERISAFE, Inc., an insurer holding company, provides workers' compensation insurance coverage in the United States. Workers' compensation policies offer benefits for injured workers, including temporary and permanent disabilities, death and reimbursements for medical and hospital costs. Workers' compensation insurance is available to small and mid-sized businesses involved in dangerous industries such as construction, trucking and logging, shipping, agricultural, maritime and oil and gaz. It was founded in 1985 in DeRidder in Louisiana.
Volume
Today's last reported volume for AMERISAFE is 35141, 66.58% below its average volume of 105144.
AMERISAFE's last close was $50.60, 22.03% under its 52-week high of $64.90.
The company's growth estimates for the current quarter and the next is a negative 37.5% and a negative 35.3%, respectively.AMERISAFE's Revenue
Year-on-year quarterly revenue growth declined by 9.6%, now sitting on 308.02M for the twelve trailing months.
AMERISAFE's Stock Yearly Top and Bottom Value
AMERISAFE's stock is valued at $51.16 at 03:16 EST, way below its 52-week high of $64.90 and way above its 52-week low of $44.06.
AMERISAFE's Moving Average
AMERISAFE's value is above its 50-day moving average of $48.27 and below its 200-day moving average of $52.71.More news about AMERISAFE.